A carregar...
Comparative pricing of branded tenofovir alafenamide/emtricitabine relative to generic tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: A cost-effectiveness analysis
BACKGROUND: Tenofovir alafenamide/emtricitabine (F/TAF) was recently approved as a non-inferior potentially safer option than tenofovir disoproxil fumarate/emtricitabine (F/TDF) for HIV pre-exposure prophylaxis (PrEP) in the US. OBJECTIVE: To estimate the greatest possible clinical benefits and econ...
Na minha lista:
| Publicado no: | Ann Intern Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217721/ https://ncbi.nlm.nih.gov/pubmed/32150602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M19-3478 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|